¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
3/25 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2023-03-23
Á¶È¸¼ö
169


¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ±è¼öÁöÀÔ´Ï´Ù.

Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº 2016³â nature communication ¿¡ ÃâÆǵÈ
"Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation" ÀÔ´Ï´Ù.

Saponin-based adjuvants (SBAs) ´Â protective cellular immunity ¸¦ À¯µµÇÏ¿© ¹é½Å º¸°­Á¦·Î »ç¿ëµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â inflammasome activation °ú antigen cross-presentation À» È°¼ºÈ­ÇÑ´Ù°í ¾Ë·ÁÁ®ÀÖÀ¸³ª ¾î¶»°Ô Ç׿ø±³Â÷Á¦½Ã°¡ À¯µµµÇ´ÂÁö ¸íÈ®È÷ ¾Ë·ÁÁø¹Ù°¡ ¾ø½À´Ï´Ù. 
ÀÌ ³í¹®¿¡¼­´Â SBAs °¡ ¼¼Æ÷ ³» lipid bodies (LBs) ¸¦ CD11b+ DC subset ¿¡¼­ À¯µµÇÏ´Â °ÍÀ» º¸¿©ÁÖ¾úÀ¸¸ç vaccination model °ú in situ tumor ablation model ¿¡¼­ LBs ÀÇ À¯µµ°¡ saponin ÀÇÁ¸Àû cross-presentation, T cell activation °ú Àΰú°ü°è°¡ ÀÖÀ½À» È®ÀÎÇß½À´Ï´Ù. 
saponin based adjuvants ÀÇ ¸ÞÄ¿´ÏÁòÀ» óÀ½À¸·Î ¹àÈù ³í¹®À¸·Î °ü·Ã ³»¿ë°ú ½ÇÇè µðÀÚÀÎÀ» °øºÎÇϱâ À§ÇØ ¼±Á¤Çß½À´Ï´Ù.

Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
¼öÁö µå¸²

³í¹®»çÀÌÆ®: https://www.nature.com/articles/ncomms13324
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
4/1 ¹ßÇ¥ ³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. À̹øÁÖ¹ßÇ¥ÀÚ ¹Î¼ºÀÔ´Ï´Ù. Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº 2020³â JEM¿¡ ÃâÆÇµÈ "Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2" ÀÔ´Ï´Ù. Antibiotic-induced dysbiosis´Â Clostridium difficile infections (CDI)ÀÇ ÁÖ¿ä ¿øÀÎÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù..
ÀÌÀü±Û
3/25 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. À̹øÁÖ¹ßÇ¥ÀÚ ¿µÁø ÀÔ´Ï´Ù. Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº 2023³â Immunity ¿¡ ÃâÆÇµÈ "Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity" ÀÔ´Ï´Ù. DopamineÀº Áß¿äÇÑneurotransmitter Áß¿¡ ÇϳªÀ̸ç, ¸é¿ª¼¼Æ÷ act..